Karypharm and Catholic University Leuven partnered to discover and develop small molecule inhibitors of exportin 1 (XPO1; CRM1)

Karyopharm Therapeutics Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Catholic University Leuven

Belgium / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced